Vani J Sabesan1, Daniel Lombardo2, Graysen Petersen-Fitts2, Martin Weisman2, Kyle Ramthun3, James Whaley3. 1. Department of Orthopaedic Surgery, Wayne State University/Oakwood, 10000 Telegraph Road, Taylor, MI, 48180, USA. sabes001@gmail.com. 2. Department of Orthopaedic Surgery, Wayne State University/Oakwood, 10000 Telegraph Road, Taylor, MI, 48180, USA. 3. Wayne State University School of Medicine, 540 East Canfield Street, Detroit, MI, 48201, USA.
Abstract
BACKGROUND: The treatment of proximal humerus fractures (PHF) is largely surgeon dependent with no clear guidelines for selecting the optimal method of treatment. AIMS: The aim of this study was to evaluate trends and variations in treatment methods of PHF in the United States from 2004 to 2012 and to determine the regional differences in treatment. METHODS: The National Inpatient Sample was used to identify all patient discharges with diagnosis codes for PHF and the data were classified based on ICD-9 procedure codes. Patient and hospital demographics were also analyzed. Simple linear regression analyses were performed for each treatment modality to evaluate current treatment trends and to extrapolate the future trends of PHF treatment over the next 20 years. RESULTS: A national estimate of 550,116 PHF discharges was identified over the time period. Significant correlations between change over time and treatment modality were found for reverse shoulder arthroplasty (RSA) (r = 0.903, p < 0.001), open reduction internal fixation (r = 0.876, p = 0.002), and closed reduction internal fixation (r = -0.922, p < 0.001). The RSA regression model showed that by the year 2032, PHF treated with RSA will increase 100% from 2012. DISCUSSION: There were significant changes in treatment modalities for PHF from 2004 to 2012; The projected number of RSA used to treat PHF will be about 9115 in 2032, compared to 340 in 2004. CONCLUSION: Overall, there was a growth in proximal humerus fractures treated in an inpatient setting in the United States. RSA had the greatest proportional increase over time, but only accounted for less than 2% of total interventions.
BACKGROUND: The treatment of proximal humerus fractures (PHF) is largely surgeon dependent with no clear guidelines for selecting the optimal method of treatment. AIMS: The aim of this study was to evaluate trends and variations in treatment methods of PHF in the United States from 2004 to 2012 and to determine the regional differences in treatment. METHODS: The National Inpatient Sample was used to identify all patient discharges with diagnosis codes for PHF and the data were classified based on ICD-9 procedure codes. Patient and hospital demographics were also analyzed. Simple linear regression analyses were performed for each treatment modality to evaluate current treatment trends and to extrapolate the future trends of PHF treatment over the next 20 years. RESULTS: A national estimate of 550,116 PHF discharges was identified over the time period. Significant correlations between change over time and treatment modality were found for reverse shoulder arthroplasty (RSA) (r = 0.903, p < 0.001), open reduction internal fixation (r = 0.876, p = 0.002), and closed reduction internal fixation (r = -0.922, p < 0.001). The RSA regression model showed that by the year 2032, PHF treated with RSA will increase 100% from 2012. DISCUSSION: There were significant changes in treatment modalities for PHF from 2004 to 2012; The projected number of RSA used to treat PHF will be about 9115 in 2032, compared to 340 in 2004. CONCLUSION: Overall, there was a growth in proximal humerus fractures treated in an inpatient setting in the United States. RSA had the greatest proportional increase over time, but only accounted for less than 2% of total interventions.
Entities:
Keywords:
National inpatient sample (NIS); Proximal humerus fracture; Reverse shoulder arthroplasty; Total shoulder arthroplasty; Treatment patterns
Authors: Jeanette Köppe; Josef Stolberg-Stolberg; Robert Rischen; Andreas Faldum; Michael J Raschke; J Christoph Katthagen Journal: Clin Orthop Relat Res Date: 2021-10-01 Impact factor: 4.755
Authors: Daniel R Evans; Eliana B Saltzman; Albert T Anastasio; Ndeye F Guisse; Elshaday S Belay; Tyler S Pidgeon; Marc J Richard; David S Ruch; Oke A Anakwenze; Mark J Gage; Christopher S Klifto Journal: JSES Int Date: 2020-12-16
Authors: Helen Razmjou; Varda van Osnabrugge; Mark Anunciacion; Andrea Nunn; Darren Drosdowech; Ania Roszkowski; Analia Szafirowicz; Dragana Boljanovic; Amy Wainwright; Diane Nam Journal: J Shoulder Elb Arthroplast Date: 2021-07-01
Authors: Rony-Orijit Dey Hazra; Johanna Illner; Karol Szewczyk; Mara Warnhoff; Alexander Ellwein; Robert Maximillian Blach; Helmut Lill; Gunnar Jensen Journal: J Clin Med Date: 2022-01-14 Impact factor: 4.241